A venture capital and private equity firm investing in companies operating in the mid-Atlantic United States.
According to Anthem Capital Management (as of December 2019), the firm has made 45 investments, has 4 companies in its portfolio, 4 exits, and is out of business. The firm focused on investing in small to middle market companies working in information technology, telecommunications, biotechnology, healthcare, and life science industries. Notable investments made by Anthem Capital Management include: Senseonics, GlycoMimetics, Echo360, Siperian, RedLasso, Defywire, GlycoMimetics, Qovia, Triumfant, Immune Control, and BioRexis.
According to Anthem Capital Management (as of December 2019), the firm has made 45 investments, has 4 companies in its portfolio, 4 exits, and is out of business. The firm focused on investing in small to middle market companies working in information technology, telecommunications, biotechnology, healthcare, and life science industries. Notable investments made by Anthem Capital Management include: Senseonics, GlycoMimetics, Echo360, Siperian, RedLasso, Defywire, GlycoMimetics, Qovia, Triumfant, Immune Control, and BioRexisBioRexis.